Comparison of treatment results of trigger finger by Corticosteroid injection and Percutaneous release
Design
Clinical trial with randomized parallel groups
Settings and conduct
Patients with trigger finger referred to Baghaei poor polyClinic and Khatam al anbia Yazd,entered the study according to inclusion criteria and after obtaining informed consent randomly assigned to one of the groups injection of steroid or Percutaneous release And are evaluated at specified intervals after the intervention.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Age over 18 years, Patients with informed consent, Patients with trigger finger symptoms based on the QUINNELL scale and Patients with no history of any previous finger surgery.
Exclusion criteria: Patients with hand tendon disorders.
Intervention groups
Intervention group: First with lidocaine 2% local anesthesia is performed and then the needle of the gage 18 is inserted through the anatomical site and attempts to release percutaneously by vertical movements over the A1 pulley.
Control group: Patients in this group will receive xylocaine 0.9 cc, bicarbonate 0.1 cc and 1 cc methylprednisolone.
Main outcome variables
Primary outcomes: Assessing the finger movement
Secondary outcomes: Pain after intervention
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20180627040252N1
Registration date:2019-12-19, 1398/09/28
Registration timing:retrospective
Last update:2019-12-19, 1398/09/28
Update count:0
Registration date
2019-12-19, 1398/09/28
Registrant information
Name
Abbas Abdoli Tafti
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 35 3522 2304
Email address
aabdoli2000@mail.ssu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2018-07-11, 1397/04/20
Expected recruitment end date
2019-06-22, 1398/04/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Treatment of trigger finger: a randomized clinical trial comparing the methods of corticosteroid injection and percutaneous release
Public title
Treatment of trigger finger
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age over 18 years
Patients with informed consent
Patients with trigger finger symptoms based on the QUINNELL scale.
Patients with no history of any previous finger surgery
Exclusion criteria:
Patients with hand tendon disorders
Age
From 18 years old
Gender
Both
Phase
2
Groups that have been masked
No information
Sample size
Target sample size:
80
Randomization (investigator's opinion)
Randomized
Randomization description
The patients will be randomly assigned to intervention and control groups using table of random numbers
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Yazd Shahid Sadoughi University of Medical Sciences
Street address
Bahonar Square
City
Yazd
Province
Yazd
Postal code
8916978477
Approval date
2018-06-26, 1397/04/05
Ethics committee reference number
IR.SSU.MEDICINE.REC.1397.051
Health conditions studied
1
Description of health condition studied
Trigger finger
ICD-10 code
M65.3
ICD-10 code description
Trigger finger
Primary outcomes
1
Description
Assessing the finger movement
Timepoint
Weeks 1, 3 and 6 and then 3 and 6 months after intervention.
Method of measurement
Physical examination
Secondary outcomes
1
Description
Pain after surgery
Timepoint
1, 3 and 6 weeks and then 3 to 6 months after intervention
Method of measurement
Visual Analogue Scale (VAS)
Intervention groups
1
Description
Intervention group: First with lidocaine 2% local anesthesia is performed and then the needle of the gage 18 is inserted through the anatomical site and attempts to release percutaneously by vertical movements over the A1 pulley.
Category
Treatment - Surgery
2
Description
Control group: Patients in this group will receive xylocaine 0.9 cc, bicarbonate 0.1 cc and 1 cc methylprednisolone.